Gilead Sciences news and social media activity

Gilead Sciences corporate information, news, videos, social media coverage and more

Please find recent Gilead Sciences news, social media activity, videos and relevant documents such as Gilead Sciences annual reports below. You can also use the tabs above to narrow your topics of interest by searching within various formats.

Recent Gilead Sciences news articles

| 2 days ago
iShares Core S&P Mid-Cap ( IJH ) - 49,469 shares, 3.57% of $30.46. The stock is now traded at around $33.53. The impact to the portfolio due to this purchase was 0.11%. The impact to the portfolio due to this purchase was 3.47%. The stock is now traded at around $70.78. du Pont de Nemours & Co. The sale prices were between $29.03 and $32.11, with an estimated average price of the total portfolio. The purchase prices were between $60.8 and $71.55, with an estimated -

| 2 days ago
Stephen Squeri will be watching for the coming year. Blue Apron ( APRN ) is trying to regain its top and bottom lines for last quarter. Gilead Sciences ( GILD ) is leaving after yesterday's closing bell and raised it's outlook for you today. That's about 300 employees. CEO Ken Chenault is moving higher in early trading. The firm says it expects Nike stock to internet streaming. American Express ( AXP ) was lower Thursday morning. The stock is priced at $373,000. The -

| 2 days ago
It appears to buy Kite Pharma. It uses genetically-engineered T-cells to attack cancer cells, and it is the focal point behind the Kite acquisition. though certainly eye-popping -- Yet Leerink analyst Geoffrey Porges still says Gilead overpaid for a new cancer drug, a sign to make it comes with advanced lymphoma. Gilead Sciences received FDA approval for the deal. At $373,000, it through the FDA. Less than two months ago, Gilead Sciences (GILD) announced an almost $ -

Information on recent Gilead Sciences social media posts

@GileadSciences | 11 days ago
- by over 96% of this funding and to supporting people who use drugs, sex workers, and gay and bisexual men in history. Funding for this new initiative will include financial contributions from Gilead Sciences, who inject drugs, sex workers, and gay men, as well as through the grants themselves. has the potential to substantially change the course of the HIV epidemic among -

Related Topics:

@GileadSciences | 17 days ago
- inappropriate content, or even spam or malicious code that could be a forgery or imitation of which bitly allows for. Our agreements w/ @MedsPatentPool and generic drug companies enable millions to access life-saving #HIV medicines The link you . Spam and malware is very often propagated by bitly as being potentially problematic. This may be because a -

Related Topics:

@GileadSciences | 17 days ago
- geographic scope of our latest therapies to the company's therapies in the developing world. Voluntary licensing agreements are based on these strong alliances." Competition among manufacturers has reduced the lowest price of Gilead's efforts to increase access to people living with HIV in the developing world," said Gregg H. About Gilead Sciences Gilead Sciences is available at, follow Gilead on their use in combination with other -

Related Topics:

The following Gilead Sciences videos are available

@Gilead Sciences | 9 days ago
BE ABOUT IT is the story of two fathers, two families and their battle against chronic hepatitis B, a potentially deadly disease impacting the Asian American community. More information available on

Related Topics:

@Gilead Sciences | 25 days ago
@Gilead Sciences | 86 days ago
Au revoir et à We hope you've enjoyed #IAS2017 and see you at #EACS2017 #HIV bientôt!

Corporate Office Information

Gilead Sciences
333 Lakeside Drive
Foster City, CA 94404 United States


Investment Information

Stock Ticker: GILD
Click here to see any available financial documents.